{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"'메타버스 ETF' 사모으는 개인투자자들","contents":"<a href=\"/news/news_read.naver?article_id=0004983060&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"'메타버스 ETF' 사모으는 개인투자자들\">'메타버스 ETF' 사모으는 개인투자자들</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004983060&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634180715583},{"title":"에스퓨얼셀, 건물용 수소연료전지로 유럽 공략 나선다","contents":"<a href=\"/news/news_read.naver?article_id=0004656491&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"에스퓨얼셀, 건물용 수소연료전지로 유럽 공략 나선다\">에스퓨얼셀, 건물용 수소연료전지로 유럽 공략 나선다</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004656491&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634180715585},{"title":"SK하이닉스, 목표가 하향… \"바닥이다 vs. 더 빠진다\"","contents":"<a href=\"/news/news_read.naver?article_id=0004656488&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"SK하이닉스, 목표가 하향… &quot;바닥이다 vs. 더 빠진다&quot;\">SK하이닉스, 목표가 하향… \"바닥이다 vs. 더 빠진다\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004656488&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634180715586},{"title":"큐리언트 \"항암치료제 Q702, 美 항암연구그룹서 발표\"","contents":"<a href=\"/news/news_read.naver?article_id=0004656481&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"큐리언트 &quot;항암치료제 Q702, 美 항암연구그룹서 발표&quot;\">큐리언트 \"항암치료제 Q702, 美 항암연구그룹서 발표\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004656481&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634180715587},{"title":"[종목속으로]공모가 한번도 넘지 못한 롯데렌탈","contents":"<a href=\"/news/news_read.naver?article_id=0004983025&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"[종목속으로]공모가 한번도 넘지 못한 롯데렌탈\">[종목속으로]공모가 한번도 넘지 못한 롯데렌탈</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004983025&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634178109577},{"title":"韓 증시, G20 중 낙폭 가장 컸다","contents":"<a href=\"/news/news_read.naver?article_id=0004983022&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211014&amp;page=1\" title=\"韓 증시, G20 중 낙폭 가장 컸다\">韓 증시, G20 중 낙폭 가장 컸다</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004983022&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211014&page=1","retrieved":1634178109578}]}